Related references
Note: Only part of the references are listed.Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
Sara Rattik et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis
Maria Apostolopoulou et al.
ACTA DIABETOLOGICA (2018)
Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis
Chaterina Sujana et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
Brendan M. Everett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Properties and functions of adipose tissue macrophages in obesity
Lucia Russo et al.
IMMUNOLOGY (2018)
RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy
Wioletta Olejarz et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Regulation of metabolism by the innate immune system
Denise E. Lackey et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance
Daniel B. Harmon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Rena M. Pollack et al.
DIABETES CARE (2016)
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
Suna Onengut-Gumuscu et al.
NATURE GENETICS (2015)
NK cells link obesity-induced adipose stress to inflammation and insulin resistance
Felix M. Wensveen et al.
NATURE IMMUNOLOGY (2015)
B-1a Lymphocytes Attenuate Insulin Resistance
Lei Shen et al.
DIABETES (2015)
gamma delta T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice
Pooja Mehta et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity
Manikandan Subramanian et al.
PLOS ONE (2015)
Associations of Circulating Lymphocyte Subpopulations with Type 2 Diabetes: Cross-Sectional Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
Nels C. Olson et al.
PLOS ONE (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans
Tracey McLaughlin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
Daniel A. Winer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)
Barbara Menart-Houtermans et al.
DIABETES CARE (2014)
Elevated Peripheral Frequencies of Th22 Cells: A Novel Potent Participant in Obesity and Type 2 Diabetes
Ruxing Zhao et al.
PLOS ONE (2014)
Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation
Satoshi Nishimura et al.
CELL METABOLISM (2013)
Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study
Carola Marzi et al.
DIABETES CARE (2013)
Increased PD-1 on CD4+CD28- T cell and soluble PD-1 ligand-1 in patients with T2DM: Association with atherosclerotic macrovascular diseases
Bimin Shi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes
Jeannig Berrou et al.
PLOS ONE (2013)
Decreased Naive and Increased Memory CD4+ T Cells Are Associated with Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
Nels C. Olson et al.
PLOS ONE (2013)
Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models
E. Ammirati et al.
Journal of the American Heart Association (2013)
T-Helper Type 1 Bias in Healthy People Is Associated With Cytomegalovirus Serology and Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
Russell P. Tracy et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications
Chun Zeng et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Adaptive immunity in obesity and insulin resistance
Henrike Sell et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus
Simona Giubilato et al.
EUROPEAN HEART JOURNAL (2011)
Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 Diabetes
Madhumita Jagannathan-Bogdan et al.
JOURNAL OF IMMUNOLOGY (2011)
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
Daniel A. Winer et al.
NATURE MEDICINE (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis
Aydin Nazmi et al.
BMC PUBLIC HEALTH (2010)
Toll-like receptors regulate B cell cytokine production in patients with diabetes
M. Jagannathan et al.
DIABETOLOGIA (2010)
T Cell-Mediated Inflammation in Adipose Tissue Does Not Cause Insulin Resistance in Hyperlipidemic Mice
Ariane Sultan et al.
CIRCULATION RESEARCH (2009)
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes The LANCET Randomized Trial
Aruna D. Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Normalization of obesity-associated insulin resistance through immunotherapy
Shawn Winer et al.
NATURE MEDICINE (2009)
Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women
Yiqing Song et al.
DIABETES (2007)
Monocytes from type 2 diabetic patients have a pro-inflammatory profile -: 1,25-Dihydroxyvitamin D3 works as anti-inflammatory
Annapaula Giulietti et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA) - Gender, ethnicity, and coronary artery calcium
DC Goff et al.
CIRCULATION (2006)
Elevated levels of interleukin-18 predict the development of type 2 diabetes - Results from the MONICA/KORA Augsburg Study, 1984-2002
B Thorand et al.
DIABETES (2005)
Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men
T Tanigawa et al.
ATHEROSCLEROSIS (2004)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
Multi-ethnic study of atherosclerosis: Objectives and design
DE Bild et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study
A Festa et al.
DIABETES (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
